Author: Socal, Mariana P; Sharfstein, Joshua M; Greene, Jeremy A
Title: The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution Cord-id: mf5v5z1n Document date: 2021_1_1
ID: mf5v5z1n
Snippet: The acute stress of the COVID-19 pandemic has laid bare a series of long-term weaknesses in the US public health system, including the fragility of our supply of essential medications.1 The virus produced unprecedented shifts in demand for old as well as new drugs, while simultaneously introducing new uncertainties about the production and distribution of pharmaceutical products. COVID-19-related shortages extended beyond antivirals to include a range of drugs broadly used in intensive care and
Document: The acute stress of the COVID-19 pandemic has laid bare a series of long-term weaknesses in the US public health system, including the fragility of our supply of essential medications.1 The virus produced unprecedented shifts in demand for old as well as new drugs, while simultaneously introducing new uncertainties about the production and distribution of pharmaceutical products. COVID-19-related shortages extended beyond antivirals to include a range of drugs broadly used in intensive care and in general hospital management (Table 1). These shortages point to serious vulnerabilities in the pharmaceutical supply chain that compromise readiness for new waves of the current pandemic and crises that are yet to come. (Am J Public Health. Published online ahead of print January 28, 2021: e1-e5. https://doi.org/10.2105/AJPH.2020.306138).
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date